Boston Scientific Corp. (BSX) Tops Q3 EPS by 5c; Issues Mixed Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
It Is the Same Old Story at Boston Scientific (BSX)
October 19, 2012 10:06 AM EDTJefferies maintained a Hold rating on Boston Scientific (NYSE: BSX) and raised its price target to $6.00 (from $5.00).
"At its core, the BSX investment story remains the same: weak end markets and completion in the two largest divisions are sapping growth and cost... More
